Krebs Biochemicals & Industries Ltd.

Market Capital
₹146 Cr.
P/E
0.00
Share Price
₹ 67.9 -0.2 (-0.29%)

Krebs Biochemicals & Industries Ltd.

Quick View
₹ 67.9 -0.2 (-0.29%)
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max
locked

Company Timeline

Company Timeline

Forensics
ROE
Financial Leverage has increased ROE over 10 years
Other Income
Other Income is not affecting ratios of the company
Capex vs ROCE
ROCE of the company has decreased even without significant capex
Depreciation Effect
Company is depreciating a greater percentage of assets. This is contributing to a reduction in Net Profit
Pledge
Promoters have not pledged a significant portion of their holding
Revenue Recognition
insufficient data
Working Capital
Working Capital of the company seems to be under control
Contingent Liabilities
Company does not have significant contingent liabilities
Retail Holding
Retail has been buying the stock which is usually a sign of exuberance
Share price
Share price has decreased over last 10 years more due to earnings
Current vs Historic Valuation
insufficient data
Promoter Holding
Promoter has not sold any shares in the last 90 days
Debt
Company might have issues servicing its debt
ROE
Latest
59.76%
3yr Average
80.41%
5yr Average
96.31%
Net Profit Margin
Latest
-75.16%
3yr Average
-71.35%
5yr Average
-61.75%
ROCE
Latest
-34.97%
3yr Average
-26.69%
5yr Average
-21.92%
Debt to Equity
Latest
-1.91
3yr Average
-2.39
5yr Average
-2.81
Revenue mix

Product Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Therapeutic Area Break-Up

Latest
|
locked
Historic
Show more
Operational Metrics

    locked
    Select a Metric
    • Management Compensation as a % of Sales (%)
    Peer Comparison
    Company Filing
    Show Previous Years
    Discussions & Analysis
    Krebs Biochemicals & Industries Ltd.
    View the discussion on ValuePickr
    Pharmaceutical Sector
    How The Pharma Industry Works - PPFAS
    Phama Industry - Terminologies and Value Chain - Alpha Invesco
    Deep Dive into Pharma Sector - Omkara Capital
    Pharma Compliance In-Depth - Amit Rajan
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Nutraceuticals- Industry Overview - Value Educator
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    timeline
    Sign Up for Free